Umbilical Cord-derived Mesenchymal Stem Cell(MSC) Transplantation(The Children's Hospital of Zhejiang University School of Medicine)

N/A

Report date: 2025/06/26 20:00:07

Base Information

Drug NameUmbilical Cord-derived Mesenchymal Stem Cell(MSC) Transplantation(The Children's Hospital of Zhejiang University School of Medicine)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsUpdating

Therapy Area/IndicationsBronchopulmonary Dysplasia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesThe Children'S Hospital, Zhejiang University School Of Medicine

China Registration ClassN/A

Develop Information

Active CompaniesThe Children'S Hospital, Zhejiang University School Of Medicine

Inactive CompaniesN/A

Active IndicationsBronchopulmonary Dysplasia

Inactive IndicationsN/A

Other Information

ATC CodeN/A